JP2023002680A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023002680A5 JP2023002680A5 JP2022167524A JP2022167524A JP2023002680A5 JP 2023002680 A5 JP2023002680 A5 JP 2023002680A5 JP 2022167524 A JP2022167524 A JP 2022167524A JP 2022167524 A JP2022167524 A JP 2022167524A JP 2023002680 A5 JP2023002680 A5 JP 2023002680A5
- Authority
- JP
- Japan
- Prior art keywords
- nanostructure
- seq
- polypeptide
- amino acid
- paramyxovirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002086 nanomaterial Substances 0.000 claims 24
- 229920001184 polypeptide Polymers 0.000 claims 23
- 108090000765 processed proteins & peptides Proteins 0.000 claims 23
- 102000004196 processed proteins & peptides Human genes 0.000 claims 23
- 241000711902 Pneumovirus Species 0.000 claims 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims 9
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 claims 8
- 230000000890 antigenic effect Effects 0.000 claims 8
- 239000012634 fragment Substances 0.000 claims 8
- 230000000712 assembly Effects 0.000 claims 7
- 238000000429 assembly Methods 0.000 claims 7
- 102000039446 nucleic acids Human genes 0.000 claims 6
- 108020004707 nucleic acids Proteins 0.000 claims 6
- 150000007523 nucleic acids Chemical class 0.000 claims 6
- 108020001507 fusion proteins Proteins 0.000 claims 5
- 102000037865 fusion proteins Human genes 0.000 claims 5
- 230000002163 immunogen Effects 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 230000003472 neutralizing effect Effects 0.000 claims 4
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 208000004692 Pneumovirus Infections Diseases 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000013604 expression vector Substances 0.000 claims 1
- 230000004927 fusion Effects 0.000 claims 1
- 229960000789 guanidine hydrochloride Drugs 0.000 claims 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 238000003259 recombinant expression Methods 0.000 claims 1
- 230000004044 response Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024132065A JP2024160321A (ja) | 2017-04-04 | 2024-08-08 | パラミクソウイルスおよび／またはニューモウイルスのｆタンパク質を表示する自己アセンブリするタンパク質ナノ構造およびその使用 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762481331P | 2017-04-04 | 2017-04-04 | |
| US62/481,331 | 2017-04-04 | ||
| PCT/US2018/025880 WO2018187325A1 (en) | 2017-04-04 | 2018-04-03 | Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus f proteins and their use |
| JP2019554692A JP7168938B2 (ja) | 2017-04-04 | 2018-04-03 | パラミクソウイルスおよび／またはニューモウイルスのｆタンパク質を表示する自己アセンブリするタンパク質ナノ構造およびその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019554692A Division JP7168938B2 (ja) | 2017-04-04 | 2018-04-03 | パラミクソウイルスおよび／またはニューモウイルスのｆタンパク質を表示する自己アセンブリするタンパク質ナノ構造およびその使用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024132065A Division JP2024160321A (ja) | 2017-04-04 | 2024-08-08 | パラミクソウイルスおよび／またはニューモウイルスのｆタンパク質を表示する自己アセンブリするタンパク質ナノ構造およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023002680A JP2023002680A (ja) | 2023-01-10 |
| JP2023002680A5 true JP2023002680A5 (enExample) | 2023-03-09 |
| JP7541701B2 JP7541701B2 (ja) | 2024-08-29 |
Family
ID=62116943
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019554692A Active JP7168938B2 (ja) | 2017-04-04 | 2018-04-03 | パラミクソウイルスおよび／またはニューモウイルスのｆタンパク質を表示する自己アセンブリするタンパク質ナノ構造およびその使用 |
| JP2022167524A Active JP7541701B2 (ja) | 2017-04-04 | 2022-10-19 | パラミクソウイルスおよび／またはニューモウイルスのｆタンパク質を表示する自己アセンブリするタンパク質ナノ構造およびその使用 |
| JP2024132065A Pending JP2024160321A (ja) | 2017-04-04 | 2024-08-08 | パラミクソウイルスおよび／またはニューモウイルスのｆタンパク質を表示する自己アセンブリするタンパク質ナノ構造およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019554692A Active JP7168938B2 (ja) | 2017-04-04 | 2018-04-03 | パラミクソウイルスおよび／またはニューモウイルスのｆタンパク質を表示する自己アセンブリするタンパク質ナノ構造およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024132065A Pending JP2024160321A (ja) | 2017-04-04 | 2024-08-08 | パラミクソウイルスおよび／またはニューモウイルスのｆタンパク質を表示する自己アセンブリするタンパク質ナノ構造およびその使用 |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US11192926B2 (enExample) |
| EP (2) | EP3606942B1 (enExample) |
| JP (3) | JP7168938B2 (enExample) |
| KR (2) | KR20240161683A (enExample) |
| CN (3) | CN115779077A (enExample) |
| AU (3) | AU2018249533C1 (enExample) |
| BR (1) | BR112019020661A2 (enExample) |
| CA (1) | CA3058794A1 (enExample) |
| DK (1) | DK3606942T3 (enExample) |
| ES (1) | ES3040563T3 (enExample) |
| FI (1) | FI3606942T3 (enExample) |
| HR (1) | HRP20251060T1 (enExample) |
| IL (2) | IL322023A (enExample) |
| LT (1) | LT3606942T (enExample) |
| MX (2) | MX2019011869A (enExample) |
| PH (1) | PH12019502276A1 (enExample) |
| PL (1) | PL3606942T3 (enExample) |
| PT (1) | PT3606942T (enExample) |
| RS (1) | RS67190B1 (enExample) |
| SG (1) | SG11201908999QA (enExample) |
| SI (1) | SI3606942T1 (enExample) |
| SM (1) | SMT202500317T1 (enExample) |
| WO (1) | WO2018187325A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9630994B2 (en) * | 2014-11-03 | 2017-04-25 | University Of Washington | Polypeptides for use in self-assembling protein nanostructures |
| AU2018249533C1 (en) | 2017-04-04 | 2023-10-12 | Institute For Research In Biomedicine | Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus f proteins and their use |
| MA54676A (fr) | 2018-01-29 | 2021-11-17 | Modernatx Inc | Vaccins à base d'arn contre le vrs |
| US11771755B2 (en) | 2018-02-28 | 2023-10-03 | University Of Washington | Self-asssembling nanostructure vaccines |
| EP3921332A2 (en) | 2019-02-08 | 2021-12-15 | The USA, as represented by The Secretary, Department of Health and Human Services | Nanoparticle-based influenza virus vaccines and uses thereof |
| EP4025587A1 (en) * | 2019-09-04 | 2022-07-13 | University of Washington | Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus f proteins and their use |
| CN110878128A (zh) * | 2019-11-04 | 2020-03-13 | 中国疾病预防控制中心病毒病预防控制所 | 一种人呼吸道合胞病毒粘膜疫苗及其制备方法和应用 |
| EP4096683A4 (en) * | 2020-01-30 | 2024-04-10 | ModernaTX, Inc. | IMMUNIZATION COMPOSITIONS FOR RESPIRATORY VIRUSES |
| AU2021221139A1 (en) * | 2020-02-14 | 2022-09-01 | University Of Washington | Polypeptides, compositions, and their use to treat or limit development of an infection |
| US20230075095A1 (en) * | 2020-02-14 | 2023-03-09 | University Of Washington | Polypeptides and their use |
| EP4161943A4 (en) * | 2020-06-09 | 2025-01-01 | Icosavax, Inc. | Method of making virus-like particle |
| CA3182021A1 (en) * | 2020-06-09 | 2021-12-16 | Scot R. Shepard | Method of assemblying two-component virus-like particle |
| CN116615235A (zh) | 2020-10-09 | 2023-08-18 | 得克萨斯州大学系统董事会 | 融合前稳定的hmpv f蛋白 |
| CN111991556B (zh) * | 2020-10-29 | 2021-03-02 | 中山大学 | SARS-CoV-2 RBD共轭纳米颗粒疫苗 |
| PE20240133A1 (es) | 2020-11-13 | 2024-01-30 | Icosavax Inc | Vacuna de nanoparticula a base de proteinas contra metapneumovirus |
| CN112778404B (zh) * | 2021-01-28 | 2022-11-29 | 中山大学 | 一种含EB病毒gHgL蛋白的自组装纳米颗粒及其制备方法与应用 |
| US20240350616A1 (en) * | 2021-08-10 | 2024-10-24 | Icosavax, Inc. | Virus-like particle vaccine for respiratory syncytial virus |
| JP2025517362A (ja) | 2022-05-17 | 2025-06-05 | アイコサバックス， インコーポレイテッド | パラミクソウイルス用の多価ワクチン及びその使用 |
| WO2024118544A2 (en) * | 2022-11-29 | 2024-06-06 | The Scripps Research Institute | Vaccines containing novel nanoparticle scaffolds |
| WO2024131862A1 (zh) * | 2022-12-22 | 2024-06-27 | 北京吉诺卫生物科技有限公司 | 一种rsv疫苗及其制备方法与应用 |
| CN118108812B (zh) * | 2023-05-04 | 2025-04-15 | 国药中生生物技术研究院有限公司 | Rsv f蛋白的突变体 |
| US20250041400A1 (en) * | 2023-07-18 | 2025-02-06 | Astrazeneca Ab | Rsv vaccine |
| WO2025093041A1 (zh) * | 2023-11-03 | 2025-05-08 | 广东蓝玉生物科技有限公司 | 非洲猪瘟病毒CD2v蛋白的免疫原性组合物及其应用 |
| CN119930762A (zh) * | 2023-11-03 | 2025-05-06 | 广东蓝玉生物科技有限公司 | 非洲猪瘟病毒ep153r蛋白的免疫原性组合物及其应用 |
Family Cites Families (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4238904A1 (de) | 1992-11-19 | 1994-05-26 | Basf Ag | Riboflavin-Synthese in Hefen |
| EA200000902A1 (ru) | 1998-03-04 | 2001-04-23 | Эксон Кемикэл Пейтентс Инк. | Способ высокотемпературной полимеризации олефинов |
| US6303767B1 (en) | 1998-11-05 | 2001-10-16 | Kosan Biosciences, Inc. | Nucleic acids encoding narbonolide polyketide synthase enzymes from streptomyces narbonensis |
| JP2000152791A (ja) | 1998-11-11 | 2000-06-06 | E I Du Pont De Nemours & Co | ルマジンシンターゼおよびリボフラビンシンターゼ |
| US20040005672A1 (en) | 2002-02-22 | 2004-01-08 | Santi Daniel V. | Heterologous production of polyketides |
| US20040214276A1 (en) | 2002-07-31 | 2004-10-28 | Chaitan Khosla | Production of glycosylated macrolides in E. coli |
| US7964196B2 (en) | 2004-05-25 | 2011-06-21 | Chimeros, Inc. | Self-assembling nanoparticle drug delivery system |
| JP2008513540A (ja) | 2004-09-21 | 2008-05-01 | メディミューン，インコーポレーテッド | 呼吸器合胞体ウイルスに対する抗体及び該ウイルス用のワクチンを製造する方法 |
| ES2719406T3 (es) | 2007-12-24 | 2019-07-10 | Id Biomedical Corp Quebec | Antígenos recombinantes del VSR |
| WO2010019725A2 (en) | 2008-08-12 | 2010-02-18 | Salemme Francis R | Node polypeptides for nanostructure assembly |
| US9102526B2 (en) | 2008-08-12 | 2015-08-11 | Imiplex Llc | Node polypeptides for nanostructure assembly |
| GB0817507D0 (en) | 2008-09-24 | 2008-10-29 | Ucl Business Plc | Protein cages |
| HRP20160859T1 (hr) | 2008-12-09 | 2016-09-23 | Novavax, Inc. | Modificirani proteini rsv f i postupci njihove upotrebe |
| US20110200560A1 (en) | 2009-05-26 | 2011-08-18 | Massachusetts Institute Of Technology | Non-ionic self-assembling peptides and uses thereof |
| WO2011017835A1 (en) | 2009-08-11 | 2011-02-17 | Nanjing University | Preparation method of protein or peptide nanoparticles for in vivo drug delivery by unfolding and refolding |
| WO2011056899A2 (en) | 2009-11-03 | 2011-05-12 | Ligocyte Pharmaceuticals, Inc. | Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps |
| DK2590675T3 (en) | 2010-07-07 | 2018-10-29 | Artificial Cell Tech Inc | ANTI-ANTI-COMPOSITIONS AND PROCEDURES FOR RESPIRATORY SYNCYTIAL VIRUS |
| WO2012158613A1 (en) | 2011-05-13 | 2012-11-22 | Novartis Ag | Pre-fusion rsv f antigens |
| US9441019B2 (en) | 2011-09-23 | 2016-09-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Influenza hemagglutinin protein-based vaccines |
| AU2013201495B2 (en) | 2011-09-30 | 2015-12-03 | Novavax, Inc. | Recombinant nanoparticle RSV F vaccine for respiratory syncytial virus |
| EP2766030A4 (en) | 2011-10-12 | 2015-09-16 | Univ Washington | MANIPULATED OUTER DOMAIN OF HV-GP120 AND MUTANTS THEREOF |
| AU2013245950B2 (en) | 2012-04-10 | 2016-04-21 | The Trustees Of The University Of Pennsylvania | Human respiratory syncytial virus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same |
| US8969521B2 (en) | 2012-04-11 | 2015-03-03 | University Of Washington Through Its Center For Commercialization | General method for designing self-assembling protein nanomaterials |
| WO2014005643A1 (en) | 2012-07-05 | 2014-01-09 | Okairos Ag | Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides |
| IN2014KN02929A (enExample) | 2012-07-06 | 2015-05-08 | Novartis Ag | |
| SI2879702T1 (sl) | 2012-08-01 | 2020-02-28 | Bavarian Nordic A/S | Cepivo na osnovi rekombinantnega modificiranega virusa vakcinacije Ankara (MVA) proti respiratornemu sincitialnemu virusu (RSV) |
| US20140141037A1 (en) | 2012-11-20 | 2014-05-22 | Novartis Ag | Rsv f prefusion trimers |
| AU2013349778A1 (en) | 2012-11-20 | 2015-05-28 | Glaxosmithkline Biologicals Sa | RSV F prefusion trimers |
| US10248758B2 (en) | 2013-02-07 | 2019-04-02 | University Of Washington Through Its Center For Commercialization | Self-assembling protein nanostructures |
| WO2014160463A1 (en) | 2013-03-13 | 2014-10-02 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Prefusion rsv f proteins and their use |
| US9738689B2 (en) | 2013-03-13 | 2017-08-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Prefusion RSV F proteins and their use |
| US9060975B2 (en) | 2013-03-14 | 2015-06-23 | Mucosis Bv | Heat-stable respiratory syncytial virus F protein oligomers and their use in immunological compositions |
| US9856313B2 (en) | 2013-03-15 | 2018-01-02 | Xiamen University | Epitope of RSV fusion protein and antibody recognizing the same |
| ME03442B (me) | 2013-04-25 | 2020-01-20 | Janssen Vaccines & Prevention Bv | Stabilizovani rastvorljivi pre-fuzioni rsv f polipeptidi |
| CN105408348B (zh) | 2013-06-17 | 2021-07-06 | 扬森疫苗与预防公司 | 稳定化的可溶性融合前rsv f多肽 |
| CN104436202B (zh) | 2013-09-12 | 2017-07-28 | 中国科学院深圳先进技术研究院 | 聚合物纳米颗粒、其制备方法及疫苗组合物、疫苗制剂及其制备方法 |
| WO2015048149A1 (en) * | 2013-09-24 | 2015-04-02 | Massachusetts Institute Of Technology | Self-assembled nanoparticle vaccines |
| US20150166610A1 (en) | 2013-10-14 | 2015-06-18 | Glaxosmithkline Biologicals, S.A. | Recombinant rsv antigens |
| EP3092245B1 (en) | 2014-01-09 | 2018-10-17 | Alpha-o Peptides AG | Flagellin-containing protein nanoparticles as a vaccine platform |
| EP2974739A1 (en) * | 2014-07-15 | 2016-01-20 | Novartis AG | RSVF trimerization domains |
| SG11201610456UA (en) | 2014-07-10 | 2017-01-27 | Janssen Vaccines & Prevention Bv | Influenza virus vaccines and uses thereof |
| US9630994B2 (en) | 2014-11-03 | 2017-04-25 | University Of Washington | Polypeptides for use in self-assembling protein nanostructures |
| SG11201705264WA (en) | 2014-12-31 | 2017-07-28 | The Usa As Represented By The Secretary Detp Of Health And Human Services | Novel multivalent nanoparticle-based vaccines |
| US10501733B2 (en) | 2015-02-27 | 2019-12-10 | University Of Washington | Polypeptide assemblies and methods for the production thereof |
| US10744193B2 (en) | 2015-03-30 | 2020-08-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Immunogenic RSV polypeptides |
| EP3319634B1 (en) | 2015-07-07 | 2019-08-21 | Janssen Vaccines & Prevention B.V. | Stabilized soluble pre-fusion rsv f polypeptides |
| EP3319633B1 (en) | 2015-07-07 | 2020-11-11 | Janssen Vaccines & Prevention B.V. | Vaccine against rsv |
| US10024198B2 (en) | 2015-08-13 | 2018-07-17 | Echogen Power Systems, Llc | Heat engine system including an integrated cooling circuit |
| US11324816B2 (en) | 2015-08-31 | 2022-05-10 | Technovax, Inc. | Human respiratory syncytial virus (HRSV) virus-like particles (VLPS) based vaccine |
| WO2017041100A2 (en) | 2015-09-03 | 2017-03-09 | Novavax, Inc. | Vaccine compositions having improved stability and immunogenicity |
| WO2017066484A2 (en) | 2015-10-13 | 2017-04-20 | Carter Daniel C | Nsp10 self-assembling fusion proteins for vaccines, therapeutics, diagnostics and other nanomaterial applications |
| EP4349405A3 (en) | 2015-10-22 | 2024-06-19 | ModernaTX, Inc. | Respiratory virus vaccines |
| WO2017075125A1 (en) | 2015-10-29 | 2017-05-04 | Emory University | Chimeric RSV, Immunogenic Compositions, and Methods of Use |
| SG10202001389PA (en) | 2015-12-23 | 2020-04-29 | Pfizer | Rsv f protein mutants |
| US11174292B2 (en) | 2016-03-29 | 2021-11-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Substitutions-modified prefusion RSV F proteins and their use |
| EP3439672B1 (en) | 2016-04-05 | 2020-11-25 | Janssen Vaccines & Prevention B.V. | Stabilized soluble pre-fusion rsv f protein for use in the prophylaxis of rsv infection |
| IL264119B2 (en) | 2016-05-30 | 2023-04-01 | Janssen Vaccines Prevention B V | f proteins of rsv are stabilized before fusion |
| WO2017207477A1 (en) | 2016-05-30 | 2017-12-07 | Janssen Vaccines & Prevention B.V. | Stabilized pre-fusion rsv f proteins |
| EP3474893A1 (en) | 2016-06-27 | 2019-05-01 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens |
| EP3554538A2 (en) | 2016-12-16 | 2019-10-23 | Institute for Research in Biomedicine | Novel recombinant prefusion rsv f proteins and uses thereof |
| AU2018249533C1 (en) * | 2017-04-04 | 2023-10-12 | Institute For Research In Biomedicine | Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus f proteins and their use |
| CN107157933B (zh) | 2017-05-04 | 2021-05-11 | 同济大学 | 一种蛋白自组装新型纳米疫苗及其制备方法 |
| US11771755B2 (en) | 2018-02-28 | 2023-10-03 | University Of Washington | Self-asssembling nanostructure vaccines |
-
2018
- 2018-04-03 AU AU2018249533A patent/AU2018249533C1/en active Active
- 2018-04-03 CA CA3058794A patent/CA3058794A1/en active Pending
- 2018-04-03 SM SM20250317T patent/SMT202500317T1/it unknown
- 2018-04-03 DK DK18723094.1T patent/DK3606942T3/da active
- 2018-04-03 KR KR1020247035024A patent/KR20240161683A/ko active Pending
- 2018-04-03 US US16/500,331 patent/US11192926B2/en active Active
- 2018-04-03 CN CN202310044111.1A patent/CN115779077A/zh active Pending
- 2018-04-03 FI FIEP18723094.1T patent/FI3606942T3/fi active
- 2018-04-03 RS RS20250807A patent/RS67190B1/sr unknown
- 2018-04-03 HR HRP20251060TT patent/HRP20251060T1/hr unknown
- 2018-04-03 SG SG11201908999Q patent/SG11201908999QA/en unknown
- 2018-04-03 ES ES18723094T patent/ES3040563T3/es active Active
- 2018-04-03 KR KR1020197029815A patent/KR102774312B1/ko active Active
- 2018-04-03 MX MX2019011869A patent/MX2019011869A/es unknown
- 2018-04-03 JP JP2019554692A patent/JP7168938B2/ja active Active
- 2018-04-03 EP EP18723094.1A patent/EP3606942B1/en active Active
- 2018-04-03 LT LTEPPCT/US2018/025880T patent/LT3606942T/lt unknown
- 2018-04-03 WO PCT/US2018/025880 patent/WO2018187325A1/en not_active Ceased
- 2018-04-03 EP EP25152898.0A patent/EP4559869A3/en active Pending
- 2018-04-03 CN CN201880023734.8A patent/CN110603262A/zh active Pending
- 2018-04-03 SI SI201831259T patent/SI3606942T1/sl unknown
- 2018-04-03 BR BR112019020661-2A patent/BR112019020661A2/pt unknown
- 2018-04-03 PT PT187230941T patent/PT3606942T/pt unknown
- 2018-04-03 CN CN202310044118.3A patent/CN115947873A/zh active Pending
- 2018-04-03 IL IL322023A patent/IL322023A/en unknown
- 2018-04-03 PL PL18723094.1T patent/PL3606942T3/pl unknown
-
2019
- 2019-09-25 IL IL26964319A patent/IL269643A/en unknown
- 2019-10-02 MX MX2023004704A patent/MX2023004704A/es unknown
- 2019-10-02 PH PH12019502276A patent/PH12019502276A1/en unknown
-
2021
- 2021-11-10 US US17/523,174 patent/US11732011B2/en active Active
-
2022
- 2022-04-27 AU AU2022202787A patent/AU2022202787C1/en active Active
- 2022-10-19 JP JP2022167524A patent/JP7541701B2/ja active Active
-
2023
- 2023-06-20 US US18/337,881 patent/US12275757B2/en active Active
-
2024
- 2024-08-08 JP JP2024132065A patent/JP2024160321A/ja active Pending
- 2024-09-26 AU AU2024220089A patent/AU2024220089A1/en active Pending
-
2025
- 2025-03-12 US US19/077,674 patent/US20250263445A1/en active Pending